Valbenazine Tosylate
Brand name: Ingrezza
Rank #34 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$553.8M
Total Cost
73,914
Total Claims
$553.8M
Total Cost
3,217
Prescribers
$7,493
Cost per Claim
1,112
Beneficiaries
74,315
30-Day Fills
$172K
Avg Cost/Provider
23
Avg Claims/Provider
Share of Medicare Part D Spending
0.20%
of total Medicare Part D spending
$553.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $553.8M total
🔎 Data Overview
Ranked #34 out of 500 drugs tracked by total cost. Valbenazine Tosylate represents a significant portion of Medicare drug spending.
At $7,493 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $172,163 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $498,064 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Valbenazine Tosylate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Robert Morton | Psychiatry | Ada, OK | 846 | $6.6M |
| 2 | Vadim Baram | Psychiatry | Saint Louis, MO | 439 | $3.5M |
| 3 | Charles Kamen | Neurology | Las Vegas, NV | 294 | $2.5M |
| 4 | Lorna Barte | Psychiatry | Camarillo, CA | 216 | $1.7M |
| 5 | Michael Ahearn | Hospitalist | Kewanee, IL | 274 | $1.4M |
| 6 | Jose Gamez | Psychiatry | Hialeah, FL | 174 | $1.4M |
| 7 | Richard Trosch | Psychiatry | Southfield, MI | 176 | $1.4M |
| 8 | Jahanbakhsh Nasserzare | Psychiatry | North Miami Beach, FL | 139 | $1.1M |
| 9 | Debra Magee | Nurse Practitioner | Wytheville, VA | 137 | $1.1M |
| 10 | Lisa Sweeney | Nurse Practitioner | West Melbourne, FL | 135 | $1.1M |
| 11 | Lora Deckard-Smart | Nurse Practitioner | Nashville, TN | 127 | $1.0M |
| 12 | Rita Ceponiene | Neurology | San Diego, CA | 75 | $951K |
| 13 | Wendy Rogers | Nurse Practitioner | Longview, TX | 107 | $931K |
| 14 | Pratap Chand | Neurology | Saint Louis, MO | 118 | $924K |
| 15 | Juliet Gatobu | Nurse Practitioner | Windcrest, TX | 121 | $921K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 31 | Pomalidomide (Pomalyst) | $589.0M | 27,253 |
| 32 | Lipase/Protease/Amylase (Zenpep) | $577.7M | 321,809 |
| 33 | Insulin Degludec (Tresiba Flextouch U-100) | $567.8M | 597,178 |
| 34 | Valbenazine Tosylate (Ingrezza) | $553.8M | 73,914 |
| 35 | Fluticasone Propion/Salmeterol (Advair Diskus) | $523.2M | 1,289,942 |
| 36 | Varicella-Zoster Ge/As01b/Pf (Shingrix) | $514.4M | 2,419,884 |
| 37 | Tafamidis (Vyndamax) | $511.1M | 20,589 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology